Array Biopharma Shares Up 96.3% Since SmarTrend's Buy Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 9 months, Array Biopharma has returned 96.27% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.